The Weekly Roundup: February 17-21

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Patrick Burnett, MD, PhD, Highlights Arcutis’ New Seborrheic Dermatitis Initiative With Odell Beckham Jr.

The overwhelmingly positive feedback from both clinicians and patients reinforces the unmet need roflumilast foam is addressing in seborrheic dermatitis care.

New Concepts in Antiaging Dermatology

New antiaging dermatology concepts target cellular senescence to slow aging and improve skin health with senotherapeutics.

Navigating Challenges to Prepare for the Future of Telehealth

Michael Rubio, PA-C, and Renata Block, MMS, PA-C discuss the complexities associated with practicing telemedicine, especially as a PA.

Rezpeg vs Existing Therapies: A Paradigm Shift in Atopic Dermatitis Treatment

Jonathan Zalevsky, PhD, discusses the fundamentally different path of Rezpeg compared with existing IL-4 and IL-13 inhibitors in atopic dermatitis.

Cross-Cultural Perspectives on Facial Aging

Recent research underscores the critical role of periorbital skin care in maintaining a youthful and healthy appearance across all ethnicities.

Jacqueline Watchmaker MD, FAAD, Discusses the Innovative InterFuse Treatment Cream for Aging Skin

“I think some key things that stand out to me are that it's safe, effective, backed by rigorous clinical data, and has very high patient satisfaction,” Watchmaker said about the new product.

AI Model Shows Promise in Reducing Skin Cancer Detection Bias

A novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or excessive hair.

Tackling Unmet Needs in Dermatology With Rezpegaldesleukin

Jonathan Zalevsky, PhD, discusses the unmet needs in atopic dermatitis treatment, the potential of Rezpeg, and the importance of novel therapies.

FDA Accepts sBLA for Dupilumab as Potential BP Treatment

Patients treated with dupilumab showed significant reductions in disease severity, itch, and corticosteroid use.

Higher Psoriatic Arthritis Disease Burden Found Among Hispanic, Non-White Patients

Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, highlighting racial and ethnic disparities in PsA disease burden and treatment outcomes.

How PathAI’s PathAssist Derm Tool Aims to Enhance Skin Cancer Diagnosis and Workflow Efficiency

Although the tool is currently designed for research use only, CEO Andy Beck, MD, PhD, is excited about its future in clinical dermatopathology.

Aesthetic Treatments: More Than Just Enhancements, A Path to Empowerment

Merz Aesthetics' global study reveals that aesthetic treatments boost self-confidence, social well-being, and self-perception beyond physical appearance.

Journal Digest: February 19

This review of the latest dermatologic studies includes insights into scuba diving's dermatological impacts, the impact of COVID-19 and vaccination on dermatological immune-mediated inflammatory diseases, and more.

At-Home Radiofrequency and Arbutin Cream Can Simultaneously Treat Melasma and Facial Aging

Positive results in melanin, erythema, wrinkles, texture, and periorbital dermal thickness were observed during the 8-week study.

Sunscreen Use Among Cyclists Falls Short

A recent study found sunscreen use is higher among women but often not reapplied properly.

FDA Clears Zabalafin Hydrogel’s Investigational New Drug Application for AD

Alphyn’s therapy uniquely treats both the immune system and bacterial components of atopic dermatitis.

VYNE Therapeutics Advances VYN202 with Phase 1b Trial in Moderate to Severe Plaque Psoriasis

VYNE has initiated a phase 1b trial for its oral BD2-selective BET inhibitor.

The Future of AI in Dermatology with Andy Beck, MD, PhD

The co-founder of PathAI and its PathAssist Derm tool believes AI is going to be incredibly valuable for dermatologists and dermatopathologists.

5-Year Study Backs Deucravacitinib’s Safety and Efficacy

The POETYK PSO LTE trial found deucravacitinib effective in sustaining PASI 75 and PASI 90 responses.

Reviewing Complex Cases: Navigating Biologics and JAK Inhibitors

At the Horizons in Advanced Practice meeting, Omar Noor, MD, FAAD, presented a case of a woman aged 25 years who presented with erythematous and scaly patches on her face, neck, and upper trunk.

Psychodermatology: An Opportunity for Collaboration Among Health Care Professionals

In this CME article, learn more about the interdisciplinary field of psychodermatology and the collaborative health care team necessary for care.

Nail Diseases in Skin of Color: A Research Gap

This study highlights the urgent need for improved awareness, diagnosis, and treatment of inflammatory nail diseases in patients with skin of color.

Ritlecitinib Generally Well-Tolerated in Pediatric Patients with Alopecia, According to Phase 1 Study

Patients aged 6 to 12 had little to no adverse events and no pharmacokinetic abnormalities were noted.

Boosting Fat Retention in Poland Syndrome

Researchers investigated whether botulinum toxin enhances fat retention, showing promising clinical results.

PRP Injection is an Effective Standalone and Combination Therapy for Rosacea

Symptoms of rosacea and dependence on oral medication were reduced in all 5 case studies.

Q&A: Terri Phillips, MD, FAAP, Explores The Psychological Impact of Aesthetic Procedures

Phillips discusses Merz Aesthetics' recent research, which highlights how aesthetic treatments boost confidence, self-perception, and emotional well-being.

Expert Panel Endorses Image-Guided Superficial Radiation Therapy as a Safe and Effective Treatment for Nonmelanoma Skin Cancer

A dermatology expert panel confirms IGSRT as a safe, effective first-line treatment for select nonmelanoma skin cancer cases.

Patients with DIMIDs and Pandemic Risks

A study found that vitiligo patients had a higher incidence of COVID-19 than those with psoriasis or atopic dermatitis.

Low-Fluence Q-Switch Laser and Tranexamic Acid Can Quickly Treat Postinflammatory Hyperpigmentation

The combination treatment safely and quickly reduced laser-induced hyperpigmentation, especially on darker skin tones.

DELTA TEEN Highlights Potential of Delgocitinib in Adolescents With Chronic Hand Eczema

The phase 3 clinical trial investigating delgocitinib cream for adolescents with moderate to severe CHE met its primary and key secondary endpoints.

Dermatological Impact of Martian Space Travel

Geological particles can cause skin irritation, allergies, and long-term dermatological conditions.

Oral Cicaglocal is an Effective Treatment for Post-Mohs Wound Healing

Satisfaction levels rose and recovery outcomes greatly improved with Cicaglocal compared to the placebo.